Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
作者信息
Gibson Amber, Nunez Cesar, Robusto Lindsay, Kammerer Brianna, Garcia Miriam, Roth Michael, Sheth Rachna, Tewari Priti, Hittle Aline, Toepfer Laurie, Torres Romeo, Short Nicholas J, Jabbour Elias, Jain Nitin, Cuglievan Branko, McCall David
机构信息
Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Department of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston TX.
出版信息
Haematologica. 2024 Sep 1;109(9):3042-3047. doi: 10.3324/haematol.2023.284950.
Abstract
摘要
Zotero 插件